16758192

Source:http://linkedlifedata.com/resource/pubmed/id/16758192

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0024314, umls-concept:C0040732, umls-concept:C0087111, umls-concept:C0205054, umls-concept:C0205225, umls-concept:C0238013, umls-concept:C0393022, umls-concept:C0449258, umls-concept:C0687676
pubmed:issue	9
pubmed:dateCreated	2006-8-25
pubmed:abstractText	We present a case of primary hepatic and possible splenic invasive aspergillosis (IA), which progressed under anti-CD20 B cell treatment for posttransplantation lymphoproliferative disease following allogeneic stem cell transplantation, to highlight the clinical value of a positive galactomannan-antigen test, an intestinal portal of entry of Aspergillus, and the detrimental effect of B lymphocyte depletion in IA.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9107334
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal..., http://linkedlifedata.com/resource/pubmed/chemical/Antifungal Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Mannans, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/Triazoles, http://linkedlifedata.com/resource/pubmed/chemical/galactomannan, http://linkedlifedata.com/resource/pubmed/chemical/rituximab, http://linkedlifedata.com/resource/pubmed/chemical/voriconazole
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0939-5555
pubmed:author	pubmed-author:BlijlevensN M ANM, pubmed-author:DonnellyJ PJP, pubmed-author:KlontR RRR, pubmed-author:VerweijP EPE, pubmed-author:van der VeldenW J F MWJ
pubmed:issnType	Print
pubmed:volume	85
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	621-3
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:16758192-Antibodies, Monoclonal, pubmed-meshheading:16758192-Antibodies, Monoclonal, Murine-Derived, pubmed-meshheading:16758192-Antifungal Agents, pubmed-meshheading:16758192-Antineoplastic Agents, pubmed-meshheading:16758192-Aspergillosis, pubmed-meshheading:16758192-Drug-Induced Liver Injury, pubmed-meshheading:16758192-Fatal Outcome, pubmed-meshheading:16758192-Female, pubmed-meshheading:16758192-Graft vs Host Disease, pubmed-meshheading:16758192-Humans, pubmed-meshheading:16758192-Liver Diseases, pubmed-meshheading:16758192-Lymphoproliferative Disorders, pubmed-meshheading:16758192-Mannans, pubmed-meshheading:16758192-Middle Aged, pubmed-meshheading:16758192-Pyrimidines, pubmed-meshheading:16758192-Splenic Diseases, pubmed-meshheading:16758192-Stem Cell Transplantation, pubmed-meshheading:16758192-Transplantation, Homologous, pubmed-meshheading:16758192-Triazoles
pubmed:year	2006
pubmed:articleTitle	Primary hepatic invasive aspergillosis with progression after rituximab therapy for a post transplantation lymphoproliferative disorder.
pubmed:publicationType	Letter, Case Reports